Fabbrocini, Gabriella

Treatment Outcomes of Immune-Related Cutaneous Adverse Events

Phillips, G. S., Wu, J., Hellmann, M. D., Postow, M. A., Rizvi, N. A., Freites-Martinez, A., Chan, D., Dusza, S., Motzer, R. J., Rosenberg, J. E., et al. (2019) · Journal of Clinical Oncology

Cancer Immunotherapy and BiomarkersChemotherapy-related skin toxicity

Cited by 241

Hidradenitis Suppurativa: Where We Are and Where We Are Going

Scala, E., Cacciapuoti, S., Garzorz-Stark, N., Megna, M., Marasca, C., Seiringer, P., Volz, T., Eyerich, K., & Fabbrocini, G. (2021) · Cells

Hidradenitis Suppurativa and TreatmentsAutoimmune and Inflammatory Disorders

Cited by 135

Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: Results from an Italian 28-week retrospective study

Megna, M., Tommasino, N., Potestio, L., Battista, T., Ruggiero, A., Noto, M., Fabbrocini, G., & Genco, L. (2022) · Journal of Dermatological Treatment

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 90

Teledermatology: a useful tool to fight COVID-19

Villani, A., Scalvenzi, M., & Fabbrocini, G. (2020) · Journal of Dermatological Treatment

Telemedicine and Telehealth ImplementationDermatological and COVID-19 studies

Cited by 88

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review

Ruggiero, A., Martora, F., Fabbrocini, G., Villani, A., Marasca, C., Megna, M., Fornaro, L., Comune, R., & Potestio, L. (2022) · Clinical, Cosmetic and Investigational Dermatology

Telemedicine and Telehealth ImplementationDermatological and COVID-19 studies

Cited by 46

Oral isotretinoin for acne: a complete overview

Villani, A., Nastro, F., Di Vico, F., Fabbrocini, G., Annunziata, M. C., & Genco, L. (2022) · Expert Opinion on Drug Safety

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 42

An Assessment of Factors Related to Tumor Thickness and Delay in Diagnosis of Melanoma in Southern Italy

Montella, M., Crispo, A., Grimaldi, M., De Marco, M. R., Ascierto, P. A., Parasole, R., Melucci, M. T., Silvestro, P., & Fabbrocini, G. (2002) · Preventive Medicine

Cutaneous Melanoma Detection and Managementmelanin and skin pigmentation

Cited by 34

Late-onset hidradenitis suppurativa: A cluster analysis of the National Italian Registry IRHIS

Cazzaniga, S., Pezzolo, E., Garcovich, S., Naldi, L., Bettoli, V., Abeni, D., Marzano, A. V., Patrizi, A., Atzori, L., Fabbrocini, G., et al. (2021) · Journal of the American Academy of Dermatology

Hidradenitis Suppurativa and TreatmentsAutoimmune and Inflammatory Disorders

Cited by 17

Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial

Dall'Oglio, F., Fabbrocini, G., Tedeschi, A., Donnarumma, M., Chiodini, P., & Micali, G. (2020) · Clinical, Cosmetic and Investigational Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 15

Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study

Villani, A., Annunziata, M. C., Cinelli, E., Donnarumma, M., Milani, M., & Fabbrocini, G. (2020) · Giornale Italiano di Dermatologia e Venereologia

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 13

Urea-containing topical formulations

Annunziata, M. C., Cacciapuoti, S., Cosentino, C., & Fabbrocini, G. (2020) · International Journal of Clinical Practice

Advancements in Transdermal Drug DeliveryDermatology and Skin Diseases

Cited by 8